EcoDrugPlus

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSOKIG00005006695
Gene Symbol: TRPA1B
1 Cross references
194 Possible Orthologues:

Trichohyalin

Ensembl ID : ENSOKIG00005009585
Gene Symbol: LOC109893193
2 Cross references
190 Possible Orthologues:

Tryptophan 5-Hydroxylase 1

Ensembl ID : ENSOKIG00005010267
Gene Symbol: LOC109894986
3 Cross references
194 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSOKIG00005016790
Gene Symbol: TPH1
3 Cross references
158 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSOKIG00005027297
Gene Symbol: TPH1
3 Cross references
194 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSOKIG00005038314
Gene Symbol: TUBA4A
1 Cross references
174 Possible Orthologues:

Tubulin Alpha Chain, Testis-Specific

Ensembl ID : ENSOKIG00005045518
Gene Symbol: LOC109880106
3 Cross references
312 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSOKIG00005049209
Gene Symbol: LOC109878275
3 Cross references
195 Possible Orthologues:

Tubulin Alpha-1b Chain-Like

Ensembl ID : ENSOKIG00005013854
Gene Symbol: LOC109869049
2 Cross references
190 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSOKIG00005024142
Gene Symbol: TUBB3
3 Cross references
145 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSOKIG00005006339
Gene Symbol: LOC109872359
3 Cross references
299 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSOKIG00005026167
Gene Symbol: LOC109874466
2 Cross references
301 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).